title: Prognosis of vasculitis associated myelodysplasia.
abstract: Systemic and immune manifestations have been reported in patients with MDS. The correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients remains controversial. Most of the authors agree that the median survival in myelodysplastic syndrome is not related to the presence of systemic and immune manifestations, but only with the existence of a systemic vasculitis.
authors.affiliation: Internal Medicine Department, University Hospital Angers, 4 rue Larey, France. cristina.belizna@wanadoo.fr
authors.forename: C
authors.initials: C
authors.lastname: Belizna
authors.forename: J F
authors.initials: JF
authors.lastname: Subra
authors.forename: D
authors.initials: D
authors.lastname: Henrion
authors.forename: A
authors.initials: A
authors.lastname: Ghali
authors.forename: G
authors.initials: G
authors.lastname: Renier
authors.forename: M
authors.initials: M
authors.lastname: Royer
authors.forename: Y Le
authors.initials: YL
authors.lastname: Corre
authors.forename: L
authors.initials: L
authors.lastname: Martin
authors.forename: J
authors.initials: J
authors.lastname: Voswinkel
authors.forename: N
authors.initials: N
authors.lastname: Ifrah
mesh_terms: D006801:Humans; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000276:immunology / Q000401:mortality* / Q000503:physiopathology; D011379:Prognosis; D056647:Systemic Vasculitis / Q000150:complications* / Q000276:immunology
keywords: Malignancy; Myelodysplasia; Prognosis; Vasculitis